Knowledge Center
Article / Mar 08, 2017
Expanding the Commercial Options
Source:
Pharma's Almanac, Q1 2017, Mar 8, 2017
Spray drying (SD) and hot-melt extrusion (HME) are commercially proven and accepted amorphous solid dispersion (ASD) technologies for the enhancement of the dissolution and bioavailability of poorly soluble drugs. These approaches are not suitable for all APIs, however. ËÄÉ«AV, in addition to offering non-ASD solutions such as nanomilling and cyclodextrin complexation, is developing an effective coprecipitation technology platform to address this key market need.
Related links
Also in the Knowledge Center
/ Apr 20, 2017
Method of production of inhalable composite particles using a three-fluid nozzle
Read more
Scientific Article
/ Dec 07, 2016
Impact of Spray Drying on Superoxide Dismutase Activity in Composite Systems with Optimal Aerodynamic Performance for Dry Powder Inhalers
Read more
Scientific Article
/ Dec 07, 2016
Optimization of Supercritical CO2 Assisted Spray Drying for the Production of Inhalable Composite Particles
Read more
Scientific Article